US Digital Health and Life Sciences Investor Active Since 1965
- Reference
- BM-08
- Origin
- United States
- Investor type
- Private equity / venture fund
- Minimum revenue
- —
- Stake sought
- Up to 49%
- Ticket size
- US$0.5–5M
- Geography
- Vietnam
Overview
Long-established US investor taking minority equity of under 50% in health and life-sciences ventures.
What the investor looks for
- Cheque US$0.5M to US$5M+, seed and Series A or technology expansion
- Pharma and medical devices, digital health and smart hospital management, specialised healthcare and pharma industrial parks
- Prefers modern systems (e.g. SAP S/4HANA) and strong founders
Companies that may fit
- SI-024
Nationwide (HQ Ho Chi Minh City)Healthcare & Pharma
Closed-loop postnatal care brand: spa chain, herbal cosmetics workshop and its own training academy, expanding by franchise.
RevenueNot disclosed
AskingUS$0.39MVND 10bn · for 30%
Stake30%
- SI-025
NationwideHealthcare & Pharma
Two-company structure: exclusive importer of US and Australian supplements plus a distributor covering all 63 provinces.
RevenueUS$3.3M
AskingUS$8.2M
Stake100%
- SI-026
Mekong Delta (next to HCMC)Healthcare & Pharma
Twenty-seven-year-old pharmacy group with a 37% regional market share, over 90% cash sales and no debt.
RevenueUS$2.7MVND 70bn
AskingUS$1.8M
Stake100%
- SI-027
Thu Duc City, Ho Chi Minh CityHealthcare & Pharma Project / greenfield
Greenfield smart-hospital project on titled healthcare land in an urban area of HCMC, designed to Japanese healthcare standards.
RevenueNot disclosed
AskingUS$25MVND 650bn
Stake100%
USD figures are indicative, converted at about VND 25,500 per US$. Figures come from the seller and are unaudited.